CytRx Hires New York Area PR, IR Firm
CytRx has hired The Investor Relations Group to handle its public relations and investor relations work, RNAi News has learned.
Tom Caden of IRG confirmed the companies’ relationship, noting that his firm has been working for CytRx for “about two or three weeks.” Caden noted that he is handling IR duties for the RNAi drug developer.
CytRx president and CEO Steven Kriegsman declined comment.
Dharmacon, Bayer Expand siRNA Reagent Deal